SCHEMBL7781772

SCHEMBL7781772

CCCS(=O)(=O)ON=C(C#N)c1ccc(SC)cc1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.36
SMN1; SMN2 Q16637 5/20 0.36
ALDH1A1 P00352 5/20 0.36
KDM4E B2RXH2 4/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
HTT P42858 2/20 0.36
TAS1R3 Q7RTX0 1/20 0.35
TAS1R1 Q7RTX1 1/20 0.35
TSHR P16473 2/20 0.34
LMNA P02545 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
GAA P10253 1/20 0.32
ALOX15 P16050 1/20 0.32
PLK1 P53350 1/20 0.32
POLB P06746 1/20 0.31
HAO1 Q9UJM8 1/20 0.30
TAS2R14 Q9NYV8 1/20 0.30
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL297765 0.85 KMT2A (0.33) MAPTSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL36729 0.85 KMT2A (0.33) MAPTSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL2702572 0.84 PLA2G7 (0.40) MAPTSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL2702574 0.84 PLA2G7 (0.40) MAPTSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL7786860 0.84 MAPT (0.41) MAPTSMN1; SMN2ALDH1A1KDM4EMEN1
SCHEMBL7786859 0.84 MAPT (0.41) MAPTSMN1; SMN2ALDH1A1KDM4EMEN1
SCHEMBL4825418 0.83 RECQL (0.39) MAPTSMN1; SMN2ALDH1A1KDM4EMEN1
SCHEMBL4825409 0.83 RECQL (0.39) MAPTSMN1; SMN2ALDH1A1KDM4EMEN1
SCHEMBL18431384 0.82 LMNA (0.33) MAPTSMN1; SMN2ALDH1A1KDM4ETSHR
SCHEMBL17557252 0.82 LMNA (0.33) MAPTSMN1; SMN2ALDH1A1KDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010037037-A1 Oximesulfonic acid esters and the use thereof as latent sulfonic acids CIBA SPEICIALTY CHEMICALS CORP. 2001-11-01 US claimed
US-20010037037-A1 Oximesulfonic acid esters and the use thereof as latent sulfonic acids CIBA SPEICIALTY CHEMICALS CORP. 2001-11-01 US disclosed
US-6017675-A POLYMERIZATION CATALYST CIBA SPECIALTY CHEMIALS CORPORATION (US) 2000-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010037037-A1 Oximesulfonic acid esters and the use thereof as latent sulfonic acids QSOX1, HAO2, PAH MAPT 4475/4885SMN1; SMN2 4161/4885ALDH1A1 160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.